MyMedicalRecords to Amend Walgreens Complaint

LOS ANGELES, CA–(Marketwired – Jul 1, 2013) –   MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, “MMR”), today announced that it will seek a stipulation or order to file an amended complaint against Walgreens Co. to include claims for infringement of its “Method for Providing a User with a Service for Accessing and Collecting Prescriptions” patent currently in the process of being issued under Notice of Allowance application number 13/714,720 which the Company received on June 19, 2013. The Prescription Management patent is directed toward online access and management of prescriptions in retail pharmacies, mass merchandisers, hospitals and others with pharmacies inside. The patent covers how consumers, patients, physicians and other healthcare professionals send prescriptions to the pharmacy, access prescriptions from a pharmacy, schedule prescription refills, send reminders regarding prescription refills including by text or email, and identify adverse drug interactions by analyzing prescription medications. Based on trends offering consumers the ability to manage prescriptions online, the Company believes this patent to be extremely relevant to its business of selling its products and services and/or licensing its patented intellectual property to healthcare professionals and others including retail pharmacies such as:

– Walgreens
– Rite Aid
– Safeway
– Wal-Mart
– Sam’s Club
– Target

The list also includes numerous other retailers offering similar services. The Company also sees its newest health IT patent as helping drive revenue to its Prepaid Personal Health Record card and intellectual property pertaining to the use of prescription drug treatment in clinical trials.

MMRGlobal already has seven issued U.S. patents pertaining to health information technologies, including U.S. Patent Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; and 8,321,240, as well as additional applications and continuation applications involving inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems in twelve additional countries including Australia, Singapore, New Zealand, Mexico, Japan, Canada, China, Hong Kong, South Korea, Israel, and European nations. The Company’s health IT patent portfolio was the subject of a May 2, 2013 report on Personal Health Records that concluded that the value of the Company’s U.S. patents could reach between $800 million to $1.1 billion in revenue (at

For additional information regarding the MyMedicalRecords, Inc. patent litigation matters, contact Ted Ward at Liner Grode Stein Yankelevitz Sunshine Regenstreif & Taylor LLP at (310) 500-3384.

About MMRGlobal
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin’s lymphoma. To learn more about MMRGlobal, Inc. visit View demos and video tutorials of the Company’s products and services at

Write a Comment

Your email address will not be published. Required fields are marked *